Open-label, non-randomised, inter-individual dose...

Open-label, non-randomised, inter-individual dose escalation of ZK 304709 with the evaluation of safety, tolerability, pharmacokinetics, oral bioavailability and orientating efficacy after daily administration in patients with advanced cancer (7 d treatment and 14 d recovery)

Janet S. Graham, Ruth Plummer, Candice McCoy, Kristin Kowal, Herbert Wiesinger, Katharina Detjen, Hilary Calvert, Bertram Wiedenmann, Jim Cassidy
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
44
Year:
2008
Language:
english
Pages:
2169
DOI:
10.1016/j.ejca.2008.06.006
File:
PDF, 152 KB
english, 2008
Conversion to is in progress
Conversion to is failed